These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 36230692)

  • 21. TRP Channels in Brain Tumors.
    Chinigò G; Castel H; Chever O; Gkika D
    Front Cell Dev Biol; 2021; 9():617801. PubMed ID: 33928077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells in the mammalian central nervous system.
    Pilkington GJ
    Cell Prolif; 2005 Dec; 38(6):423-33. PubMed ID: 16300654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.
    Harrup R; White VM; Coory M; Walker R; Anazodo A; Skaczkowski G; Bibby H; Osborn M; Phillips MB; Conyers R; Thompson K; Orme LM; Pinkerton R; Nicholls W
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):202-208. PubMed ID: 32856982
    [No Abstract]   [Full Text] [Related]  

  • 25. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agents.
    Mander K; Harford-Wright E; Lewis KM; Vink R
    Recent Pat CNS Drug Discov; 2014; 9(2):110-21. PubMed ID: 25386916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review.
    Solomou G; Gharooni AA; Patel W; Gillespie CS; Gough M; Venkatesh A; Poon MTC; Wykes V; Price SJ; Jenkinson MD; Watts C; Plaha P
    BMJ Open; 2022 Jul; 12(7):e056059. PubMed ID: 35868820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
    Benesch M; Wagner S; Berthold F; Wolff JE
    J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma.
    Karremann M; Rausche U; Roth D; Kühn A; Pietsch T; Gielen GH; Warmuth-Metz M; Kortmann RD; Straeter R; Gnekow A; Wolff JE; Kramm CM
    Br J Cancer; 2013 Aug; 109(4):844-51. PubMed ID: 23868007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary brain tumours in adults.
    Lapointe S; Perry A; Butowski NA
    Lancet; 2018 Aug; 392(10145):432-446. PubMed ID: 30060998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
    Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
    J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top".
    Simonelli M; Persico P; Perrino M; Zucali PA; Navarria P; Pessina F; Scorsetti M; Bello L; Santoro A
    Cancer Treat Rev; 2018 Sep; 69():121-131. PubMed ID: 29966936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Immunotherapeutic Approaches for Malignant Gliomas.
    Han MH; Kim CH
    Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.
    Capatina AL; Lagos D; Brackenbury WJ
    Rev Physiol Biochem Pharmacol; 2022; 183():1-43. PubMed ID: 32865696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of glial and non-glial brain tumours in Europe.
    Crocetti E; Trama A; Stiller C; Caldarella A; Soffietti R; Jaal J; Weber DC; Ricardi U; Slowinski J; Brandes A;
    Eur J Cancer; 2012 Jul; 48(10):1532-42. PubMed ID: 22227039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium Channels in Cancer.
    Ganser K; Klumpp L; Bischof H; Lukowski R; Eckert F; Huber SM
    Handb Exp Pharmacol; 2021; 267():253-275. PubMed ID: 33864122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.